Opioid receptors in human neoplasms: growth hormone and prolactin response to morphine, met-enkephalin and buprenorphine in cancer patients.
Lissoni
P
P
Division of Radiation Oncology, Ospedale San Gerardo, Monza, Italy.
Barni
S
S
Garuti
F
F
Astuti
R
R
Tancini
G
G
D000328:Adult; D000368:Aged; D002047:Buprenorphine / Q000494:pharmacology*; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives / Q000494:pharmacology*; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000494:pharmacology*; D009369:Neoplasms / Q000378:metabolism*; D011388:Prolactin / Q000097:blood*; D011863:Radioimmunoassay; D011957:Receptors, Opioid / Q000378:metabolism*; D013997:Time Factors
D011957:Receptors, Opioid; D002047:Buprenorphine; D004744:Enkephalin, Methionine; D009020:Morphine; D011388:Prolactin; D013006:Growth Hormone